This report highlights the issue of continued loss of lean tissue with weight regain in the long term following Roux-en-Y gastric bypass. The association between the loss of lean tissue and decreased handgrip strength is clinically important given its implication for diminished functional status, particularly in light of the aging obese population and the increasing rates of bariatric surgery in the United States.
Introduction
The Roux-en-Y gastric bypass (RYGB) is a restrictive and malabsorptive procedure that reduces stomach capacity to approximately 1 ounce, bypasses part of the small intestine, and decreases nutrient absorption. Although overt macronutrient malabsorption is rarely reported, possible adverse outcomes of RYGB include protein deficiency, bone loss, abnormal fluid distribution, and excessive lean tissue loss. [1] [2] [3] [4] While body composition has been measured by many groups in the first year after surgery, [5] [6] [7] [8] [9] [10] [11] [12] few data exist regarding the impact of RYGB on body composition between 5 and 10 years after surgery. As might be expected, fat mass (FM) 5, 8, [10] [11] [12] and percent body fat 5, 6, 10, 11 have been observed to substantially decrease in the first year after RYGB; however, fat-free mass (FFM) also decreases after surgery, albeit to a lesser extent.
The degree to which FFM is lost in the first year after surgery varies among individuals undergoing RYGB and is influenced by factors including dietary protein intake, exercise and mobility, and inflammation. [13] [14] [15] [16] It is not well studied what impact the changes in body composition, particularly FFM, may have on muscle strength and function over a 5-to 10-year period post-RYGB. Our aim was to evaluate changes in body composition and handgrip strength as a measure of functional status in participants from a previous 1-year post-RYGB longitudinal study who had undergone RYGB approximately 9 years prior.
Methods

Study Participants
As has been previously described, 17 women with class III obesity (body mass index [BMI] ≥40 kg/m 2 ) who planned to undergo RYGB surgery at the Weight Loss Management and Surgery Center at University of Minnesota Health were recruited for the original 1-year longitudinal study between 2005 and 2007 . 17 The follow-up assessment of these original participants was completed during 2014 and 2015. Both the original study and the follow-up protocol were approved by the University of Minnesota Institutional Review Board (IRB) and the Clinical and Translational Science Institute (CTSI). Returning participants were compensated for their time. The 20 original participants who attended at least 3 study visits as part of the original study were recontacted through an IRBapproved mailed letter and asked to return for 1 study visit. Individuals were excluded from the original study and followup if they (1) were taking medications known to influence body composition (eg, corticosteroids, anabolic steroids); (2) had a pacemaker or other internally placed biomedical device; (3) had conditions associated with significant hydration changes and/or metabolic disturbances, such as pulmonary hypertension, congestive heart failure, abnormal thyroid function indices, neoplastic disease, liver failure, renal failure, type 1 diabetes, and poorly controlled type 2 diabetes; or (4) were pregnant. The original cohort was limited to women to maximize the homogeneity of the sample given the significant differences in body composition between men and women and because at the time of recruitment, only ~15% of the patients undergoing RYGB at our site were male.
Long-Term Body Composition Changes in Women Following Roux-en-Y Gastric Bypass Surgery
Follow-Up Study Protocol
The day before testing, participants were asked to avoid alcohol and vigorous exercise and to maintain their usual fluid intake, limiting water consumption to no more than 250 mL water during the 2 hours just prior to testing. The study visit began in the morning after a 12-hour fast. Participants remained fasted throughout all visit procedures.
Anthropometric measurements. Each participant's height was measured to the nearest 0.1 cm using a wall-mounted stadiometer (model S100; AYRTON, Prior Lake, MN) and weight was measured to the nearest 0.1 kg using a stand-on digital scale (model 5002; SCALE-TRONIX, White Plains, NY). Waist and hip circumference were measured following standardized procedures as outlined in the Anthropometric Standardization Reference Manual. 18 Total body water and extracellular water. To measure total body water (TBW), participants consumed 25 g of a 16% (wt/ wt) solution of deuterium oxide, prepared following the method described in Trabulsi et al 19 (supplying 4 g of 99.9% 2 H 2 O per preweighted dose; Sigma-Aldrich, St Louis, MO) in tap water, followed by a 25-mL tap water rinse. To measure extracellular water (ECW), participants consumed 1 g/kg of a 3% (wt/vol) sodium bromide solution (Fisher Scientific, Pittsburgh, PA) in tap water followed by a 25-mL tap water rinse. Serum samples were collected for analysis of bromide enrichment before dosing and 4 and 5 hours postdose. In all cases, the 4-hour enrichment was lower than the 5-hour enrichment, thus, the 5-hour time point was used for data analysis. Urine samples were collected for analysis of deuterium enrichment before dosing and 3, 4, and 5 hours postdose. The average of 3-, 4-, and 5-hour time points was used for data analysis. Participants were asked to void their bladders hourly during the study visit, and they did not break their fast or consume any additional fluids throughout the 5-hour postdose equilibration period. Urine samples were analyzed for deuterium enrichment by the laboratory of Dr Dale Schoeller (University of Wisconsin, Madison, WI). [19] [20] [21] TBW was determined from the deuterium space after reducing it by 4% to correct for exchange with the nonaqueous compartment. 21 Serum samples were analyzed by high-performance liquid chromatography for bromide by the laboratory of Dr Jennifer Rood (Pennington Biomedical Research Center, Baton Rouge, LA). 22, 23 The bromide dilution space was used to calculate ECW using the following equation:
where 0.95 is the Donnan equilibrium correction and 0.9 corrects for the intracellular distribution (including red blood cells). 21 
From 1
The original TBW and ECW data collected during the first year of weight loss following RYGB were used for comparison with the long-term follow-up data. For the first year of the study, we completed multiple dilution using a peripheral intravenous (IV) dosing protocol for deuterium and sodium bromide as has been previously reported. 24 For baseline (1 month pre-RYGB), 1.5 months, 6 months, and 1 year post-RYGB, TBW was calculated from the average deuterium enrichment of the 3-hour and 4-hour urine samples. For the same 4 time points, ECW was calculated from the 4-hour post-sodium bromide infusion serum sample. For all time points, ECW and TBW were converted to kilograms by multiplying by 0.993 (the density of water at 37°C). Oral dosing should result in slower equilibration time than IV dosing for both deuterium and bromide, and thus we extended the equilibration time by 1 hour for the final follow-up visit.
Body composition by air displacement plethysmography. Body composition was assessed by air displacement plethysmography (ADP) using the BOD POD (COSMED USA, Inc, Concord, CA) only at the follow-up study visit and was not part of the original study protocol. The standard BOD POD protocol was followed. The BOD POD was calibrated each day before use. Body weight was measured using the device's electronic scale that was calibrated biweekly. Participants wore tight-fitting Lycra or spandex swimwear or lightweight sports bra and close-fitting underwear and covered their hair with a tight-fitting swim cap. Participants were instructed to remove all metal and jewelry before entering the machine. The device reports the average of 2 raw body volume measurements. The Siri model was used to estimate body composition. 25 When the participant was capable of doing so, thoracic gas volume (TGV) was measured using the device. TGV measurement was repeated until a merit value (<1.0) was obtained to signify compliance with the TGV protocol. For the 1 participant who was unable to complete the TGV measurement, the devicepredicted TGV result was used. Calculations were performed by the BOD POD's software (version 5.4.0). Repeat measurements of body volume using BOD POD have been shown to result in an error equivalent to 0.8% body fat. 26 Body composition by dual-energy x-ray absorptiometry. As described by Levitt et al, 24 dual-energy x-ray absorptiometry (DXA) scans from the original study were performed on the GE Lunar Prodigy (GE Healthcare, Piscataway, NJ). By the time of the long-term follow-up visit, the CTSI had discontinued the use of the GE Lunar Prodigy. Therefore, follow-up scans were performed on the GE Lunar iDXA (GE Healthcare). At baseline, study participants were too heavy and/or large to obtain a whole-body scan using the available standardsized DXA instrument; thus, half-scans were performed 27, 28 and, for consistency, for all study visits up to 1 year post-RYGB. At the 9-year follow-up visit, both whole-and halfbody scans were obtained for 4 of the 5 individuals for whom it was possible, using the iDXA instrument. It has been reported that mirrored half-body scans are comparable to whole-body scans using the iDXA. 28 Half-body scans from baseline, 1.5 months, 6 months, and 1 year post-RYGB were reanalyzed using the Lunar iDXA software. The right-side half-body scans were mirrored around the midline to create a "whole" individual for analysis. For each original (baseline, 1.5 months, 6 months, 1 year) scan, study participants were scanned using an acrylic board to separate arm tissue from breast tissue as previously described. 24 Reanalysis of the isolated board using the new software indicated that it was interpreted by the iDXA as contributing the whole-body equivalent of 1.165 kg to fat mass (FM) and 0.365 kg fat-free mass (FFM). Thus, these values were subtracted from the results for mirrored body FM, LST, and FFM from the original scans. No corrections were made to the mirrored half-body scans for the long-term follow-up visit because an acrylic board was not used. Precision of the iDXA instrument has been reported to be <1% for whole-body bone mineral content (BMC) 29 , and REE were averaged for the time period from 6-20 minutes, which for all individuals had coefficients of variation ≤10%, interpreted as steady state. REE measurements were available for all participants using the same protocol and device for the 1-year and 9-years post-RYGB visits. Pre-RYGB data were not available using the Parvo Medics device.
Handgrip strength. Handgrip muscle strength was measured using a digital isokinetic hand dynamometer (Model T.K.K.5401, Grip D; Takei Scientific Instruments, Ltd, Tokyo, Japan). Handgrip strength was assessed with participants in a standing position. Participants were asked to keep their arm straight (elbow at full extension) and hanging by the side of their body and were asked to squeeze the dynamometer with as much force as possible without changing their body position or leaning to one side. Two measurements were taken from the right and left hands consecutively (R, L, R, L) and the 4 measurements were averaged. Handgrip assessment was completed at all study visits following the same protocol. 
Statistics
Statistical analyses were performed using SAS software, version 9.4 (SAS Institute, Cary, NC) and GraphPad Prism version 6.0 for Mac OS-X (GraphPad Software, La Jolla, CA).
Values are expressed as means ± standard deviations (SDs), unless otherwise indicated. Nonparametric Friedman analysis of variance was used to assess overall differences in body composition measurements over the 5 time points for which data were available. Paired t tests were used to evaluate weight, body composition, and strength changes between 1 year and mean follow-up time of 9 years. A general linear model for repeated measures was used to determine the relationships between handgrip strength, LST, and age. For all tests, P < .05 was considered significant. Pearson's correlation (r) is reported for comparisons between methods.
Results
Participant Characteristics
Of the 20 white female participants who completed the original study, 10 expressed interest in returning to the study when they were contacted between 8 and 9 years after the original study. Two of these 10 individuals declined to participate in the follow-up study, 3 were lost to follow-up after originally expressing interest, and 5 individuals completed the follow-up study visit. All women were seen for the final follow-up between 8 and 9 years after surgery. Mean time to final long-term followup visit was 8.7 ± 0.3 years after surgery (see Table 1 ). Mean age for these 5 women at time of surgery was 47.2 ± 10.9 years; at last follow-up visit, mean age was 56.2 ± 10.9 years. Most (4 of 5) women were postmenopausal at the time of final followup. One individual had diabetes (most recent hemoglobin A1C Data are reported for n = 5. All values are reported as mean ± SD. Time points are baseline (1 month pre-RYGB) and 1.5 months, 6 months, 1 year, and 9 years post-RYGB surgery. Changes over the entire follow-up period post-RYGB were evaluated using nonparametric Friedman's test; P < .05 considered significant. Select comparisons between 1-year and 9-year values for weight, DXA tissue compartments, and handgrip strength were evaluated by paired t test. b Indicates significant difference from 1 year by paired t test (P < .05). of 7.6 mg/dL) and was taking insulin; all other individuals were nondiabetic. Fasting blood glucose was within normal limits (defined as >70 mg/dL and <99 mg/dL) at the follow-up visit for all participants. For the first 3 reported time points (baseline, 1.5 months, and 6 months) post-RYGB, the individual with diabetes exhibited elevated fasting blood glucose levels. Table 1 shows the body composition data for the 5 participants at baseline, 1.5 months, 6 months, 1 year, and 9 years after surgery. Data were available for all 5 returning study participants at each aforementioned time point. Average weight loss 1 year postsurgery was 46.2 ± 10.2 kg. Participants regained 5.5 ± 6.7 kg of body weight between the 1-year and 9-year visits, although this was not significant (P = .15). DXA data for each time point are reported in Table 1 , and individual data for each study participant are displayed in Figure 1 . There was a trend toward decreased LST, FFM, and BMC (Table 1, Figure 1 ). Mean LST loss over the 9 years was 11.9 ± 5.6 kg. In addition, 9-year LST was 4.4 ± 3.0 kg lower than 1-year post-RYGB (P = .0327). Unlike LST, mean FM decreased after surgery by 39.9 ± 8.32 kg but then treaded toward an increase of 8.6 ± 7.0 kg between 1 year and 9 years (P = .0527).
Changes in Body Composition and Handgrip Strength
Interestingly, mean handgrip strength decreased over the 9-year period from 31.9 ± 6.1 to 26.2 ± 4.5 kg of force (Table 1 and Figure 2A) . Between 1 year and 9 years, mean handgrip strength decreased by 3.0 ± 2.2 kg of force (P = .0409). When including all points in the data set and not accounting for the effect of each visit, handgrip force was moderately correlated with DXA LST (r = 0.64, P = .0005, r 2 = 0.41, n = 25 pairs) ( Figure 2B ). To control for the effect of visits and aging over the course of the study, handgrip strength was assessed as a function of DXA LST, age, and visit. Fitting a general linear model for handgrip strength with LST, age, visit, and time since surgery, we found that LST (P < .0001) and age (P < .0001) were significant contributors to the model. The model containing LST, age, and visit accounted for 84% of the variation in handgrip strength in this small cohort. LST was highly correlated with body weight (r = 0.94, P < .0001). To account for the contribution of body weight to LST we also assessed a model containing the percentage of body weight from LST (where percentage of body weight from LST is expressed as %LST = LST/weight × 100), age, and visit. Table 1 for mean values and significance.
In this model, both %LST and age were significant (P = .003 and .0002, respectively), and the model accounted for 62% of the variation in handgrip strength. Figure 2C shows the handgrip measurements by age for each visit plotted in comparison to the manufacturer's normal values for each age between 33 and 68 years (T.K.K.5401, Grip D, manual). At the final follow-up visit, 3 of 5 individuals demonstrated below-normal functional status for their age, and 2 of these 3 individuals had previously been classified as having normal handgrip force for their age pre-RYGB.
Comparison of FM and FFM by Multiple Methods at 9 Years Post-RYGB
We calculated FM and FFM by the 4-component model, which uses body weight, BMC, TBW, and body volume, and compared it with FM and FFM from ADP (calculated using the Siri model 25 ), as well as FM and FFM from DXA ( Figure 3A,B) ; all 3 methods for FM and FFM were highly correlated (r > 0.98, P < .001). 
Discussion
To our knowledge, this is one of the first studies to comprehensively assess changes in body composition and strength beyond 5 years after RYGB. The most important finding from our study is the concerning trend of continued LST loss over the 9-year period accompanied by a trend toward weight regain, primarily as FM, beginning after 1 year. The importance of the LST loss was underscored by a strong association with diminished handgrip strength.
Our 1-year post-RYGB body composition data agree with other published reports. [5] [6] [7] [8] [9] [10] [11] 33, 34 In our participants, FM comprised ~84% of DXA total mass loss at 1 year post-RYGB. FM loss as a percentage of weight loss has been reported to be between 73% and 80% at 6 months to 1 year after RYGB. [5] [6] [7] [8] 11, 24, 33, 35 We also observed that LST loss was ~16% of DXA total mass loss at 1 year post-RYGB. FFM loss has been reported to be between 18% and 25% of weight loss 1 year after RYGB, [5] [6] [7] [8] 35 and LST loss has been reported to be between 12% and 23% of weight loss 1 year after RYGB. 11, 33 On average, between 1 year and 9 years, our participants lost 4.4 kg LST and gained 8.6 kg FM with weight regain of 5.5 kg (~14% of weight lost). While LST loss was significant in our sample, FM and weight regain could only be considered trends. One recent study (n = 300) reported that mean weight regain as a percentage of weight lost was 23% at 7 years after surgery.
36 At 1 year post-RYGB, our participants had ~38% body fat, and at 9 years, that number had increased to ~45%. Although our sample size was small, this might suggest that important body composition changes could go unnoticed in a clinical setting where only body weight is monitored.
Individuals with obesity have been found to have abnormal fluid distribution characterized by a relative expansion of the ECW compartment compared with the intracellular water (ICW) compartment; this is typically assumed to be due to higher levels of adiposity. 24 Elevated ECW/ICW ratios ranging from 0.80-1.48 have been reported in individuals undergoing bariatric surgery, 8, [37] [38] [39] [40] compared with 0.63 in lean individuals. 37, 38 The obesity-associated expansion of ECW does not appear to normalize after significant weight loss, with investigators reporting no change in the ECW compartment following weight stabilization over the first 1-2 years after various bariatric surgeries. 24, 37, 39, 40 Our data were in agreement with this; ECW/ICW values at all time points of our 9-year study period were higher than those reported for lean individuals. 37, 38 Although the clinical relevance of the observed relative expansion of ECW before and after RYGB is not well understood, it does have ramifications for body composition assessment because changes in fluid distribution violate the underlying assumptions of 2-compartment measurement methods such as densitometry (eg, ADP) and deuterium dilution. Most notably, the assumptions that FFM is hydrated at 73.8% 41 and that the body has a density of 1.1 g/mL 25 may not hold true in the obese and postobese state, as observed by others. 8, [37] [38] [39] Our 4-component measurements appeared to agree well with ADP and DXA measures at 9 years, given that the mean hydration of FFM (defined as TBW/DXA FFM) was normal at 73%.
Our finding that handgrip strength had diminished significantly by 9 years is important in light of the observed association with loss of LST. In our study, 3 of 5 individuals demonstrated below-normal functional status for their age at the 9-year visit, and 2 of these 3 individuals had been classified as having normal handgrip force for their age before surgery. We cannot say definitively that the loss of LST accounted for the reduction in handgrip strength. It is possible that weight regain and continued loss of lean tissue were related to a lack of physical activity. Reid et al 42 reported that in a cohort of 89 individuals with a mean age of 50 years ~9 years after bariatric surgery, most do not meet current recommended step-per-day guidelines for physical activity. More work is needed to determine if a lack of physical activity, independent of aging and other factors, is contributing to the apparent decrease in LST and functional strength.
Limitations
We recognize that there were a number of limitations with our study. This long-term follow-up study had a small sample size. We found that ~9 years post-RYGB, only 25% of participants who completed our original study were willing to return. This underscores the difficulties for long-term follow-up studies in this population, particularly in geographical locations such as ours where individuals travel long distances to undergo bariatric surgery at a center for excellence.
Our study did not incorporate any male participants because the original study was drawn from a clinic where only 15% of patients were male and all 20 original study participants were female. It is possible that changes in body composition for male patients after RYGB are different from those seen in female patients, although it has not been studied, given that most studies focus on female patients. There was also an inherent bias in our study sample. We do not know anything about the long-term weight loss success in the 15 women who did not return for follow-up, and it is possible that our return cohort was self-selected to include individuals who perceived that they had maintained their weight loss since the original study ended. In addition, given the long time frame between the original study and the follow-up, several of the methods used were different, as has been described in detail in the Methods. For example, oral dosing was used in place of IV dosing for deuterium and bromide dilution, and the original DXA instrument had been replaced by a newer instrument. Finally, in any future assessments of the relationship between lean tissue and functional status, it will be important to control for dietary protein intake and physical activity.
Future Directions
This study highlights the challenges inherent in completing long-term follow-up assessments of individuals after bariatric surgery. Studies in this population are clearly needed to identify contributors to deleterious changes in body composition and to determine if behavioral and/or physical activity interventions can be protective of lean body mass. Following a large cohort over many years may not be feasible given low rates of return seen in our study, and therefore a cross-sectional assessment including detailed body composition assessment (ie, using DXA, multiple dilution, or other reference techniques) and using robust epidemiological methods may prove to be the most effective way to assess body composition changes in the long term after bariatric surgery.
Conclusions
The continued loss of lean mass during the first decade following RYGB surgery is a concerning trend in this population. This, combined with the relationship between loss of handgrip strength and LST while controlling for age, further indicates that in the long term, there may be physiologically important loss of muscle mass and function in this population. Our data highlight the need for closer monitoring of body composition and suggest that clinical protocols to maintain LST and muscle strength may be warranted after bariatric surgery. Future work that controls for confounding variables in a larger postbariatric cohort is needed to confirm our finding of lean tissue loss, elucidate its impact on functional status, and demonstrate if it is preventable with exercise and nutrition intervention.
